• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nationwide epidemiological study of neuromyelitis optica in Japan.

作者信息

Miyamoto Katsuichi, Fujihara Kazuo, Kira Jun-Ichi, Kuriyama Nagato, Matsui Makoto, Tamakoshi Akiko, Kusunoki Susumu

机构信息

Department of Neurology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.

Department Multiple Sclerosis and Therapeutics, Fukushima Medical University, Koriyama, Japan.

出版信息

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):667-668. doi: 10.1136/jnnp-2017-317321. Epub 2018 Jan 11.

DOI:10.1136/jnnp-2017-317321
PMID:29326292
Abstract
摘要

相似文献

1
Nationwide epidemiological study of neuromyelitis optica in Japan.日本视神经脊髓炎的全国性流行病学研究。
J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):667-668. doi: 10.1136/jnnp-2017-317321. Epub 2018 Jan 11.
2
[Epidemiology of multiple sclerosis and neuromyelitis optica].[多发性硬化症与视神经脊髓炎的流行病学]
Nihon Rinsho. 2014 Nov;72(11):1903-7.
3
[Epidemiology of neuromyelitis optica].视神经脊髓炎的流行病学
Nihon Rinsho. 2015 Sep;73 Suppl 7:260-4.
4
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.日本多发性硬化症和视神经脊髓炎病情加重的季节性
Mult Scler. 2013 Mar;19(3):378-9. doi: 10.1177/1352458512452332. Epub 2012 Jun 21.
5
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.AQP4 抗体阳性视神经脊髓炎谱系障碍患者的预后因素和疾病进程：来自英国和日本的研究。
Brain. 2012 Jun;135(Pt 6):1834-49. doi: 10.1093/brain/aws109. Epub 2012 May 9.
6
Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.日本北部视神经脊髓炎谱系障碍的患病率及临床特征
Neurology. 2017 Nov 7;89(19):1995-2001. doi: 10.1212/WNL.0000000000004611. Epub 2017 Oct 6.
7
Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.神经免疫学：在视神经脊髓炎的诊断上更进一步。
Nat Rev Neurol. 2014 Dec;10(12):679-81. doi: 10.1038/nrneurol.2014.216. Epub 2014 Nov 11.
8
Prevalence, incidence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.日本北部视神经脊髓炎谱系障碍的患病率、发病率及临床特征
J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):494-495. doi: 10.1136/jnnp-2022-330274. Epub 2022 Nov 30.
9
[Topics of neuromyelitis optica].[视神经脊髓炎的主题]
Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):468-74. doi: 10.2177/jsci.37.468.
10
Neuromyelitis optica: effect of gender.视神经脊髓炎：性别影响
J Neurol Sci. 2009 Nov 15;286(1-2):18-23. doi: 10.1016/j.jns.2009.08.045. Epub 2009 Sep 8.

引用本文的文献

1
The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population.美国人群中血清阳性视神经脊髓炎谱系障碍的流行病学及临床表现
Ann Clin Transl Neurol. 2025 Jan;12(1):169-179. doi: 10.1002/acn3.52268. Epub 2024 Dec 21.
2
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 6-month Interim Analysis of Post-marketing Surveillance.萨特利珠单抗在日本视神经脊髓炎谱系障碍患者中的安全性和有效性：上市后监测的6个月中期分析
Neurol Ther. 2024 Oct;13(5):1361-1383. doi: 10.1007/s40120-024-00640-7. Epub 2024 Jul 16.
3
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
AQP4 抗体相关 NMOSD 的性别比和发病年龄：综述和荟萃分析。
J Neurol. 2024 Aug;271(8):4794-4812. doi: 10.1007/s00415-024-12452-8. Epub 2024 Jul 3.
4
Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience.巴西髓鞘少突胶质细胞糖蛋白抗体相关性疾病的临床谱：单中心经验。
Arq Neuropsiquiatr. 2023 Nov;81(11):980-988. doi: 10.1055/s-0043-1777002. Epub 2023 Nov 30.
5
Prevalence, Clinical Profiles, and Prognosis of Stiff-Person Syndrome in a Japanese Nationwide Survey.日本全国性调查中的僵人综合征的患病率、临床特征和预后。
Neurol Neuroimmunol Neuroinflamm. 2023 Sep 22;10(6). doi: 10.1212/NXI.0000000000200165. Print 2023 Nov.
6
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.视神经脊髓炎谱系疾病（NMOSD）的诊断和治疗进展 - 视神经脊髓炎研究组（NEMOS）的修订建议。第一部分：诊断和鉴别诊断。
J Neurol. 2023 Jul;270(7):3341-3368. doi: 10.1007/s00415-023-11634-0. Epub 2023 Apr 6.
7
Incidence of neuromyelitis optica spectrum disorders in China: a large cohort study using claim data.中国视神经脊髓炎谱系疾病的发病率：一项基于理赔数据的大型队列研究。
BMJ Open. 2022 Jan 31;12(1):e048942. doi: 10.1136/bmjopen-2021-048942.
8
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases.新冠疫苗在罕见神经免疫性疾病患者中的安全性和耐受性的患者报告。
Mult Scler Relat Disord. 2021 Oct;55:103189. doi: 10.1016/j.msard.2021.103189. Epub 2021 Aug 2.
9
Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study.中国视神经脊髓炎谱系障碍（NMOSD）的发病率：一项基于全国人口的研究。
Lancet Reg Health West Pac. 2020 Sep 6;2:100021. doi: 10.1016/j.lanwpc.2020.100021. eCollection 2020 Sep.
10
Paraneoplastic neuromyelitis optica spectrum disorder associated with malignant melanoma: A case report.副肿瘤性视神经脊髓炎谱系疾病合并恶性黑色素瘤 1 例报告。
Thorac Cancer. 2021 Jun;12(11):1775-1779. doi: 10.1111/1759-7714.13965. Epub 2021 May 5.